Clinical Trial Update: Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating mycophenolate mofetil, tacrolimus, daclizumab, and donor peripheral stem cell transplantation for hematologic cancers; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes

Drugs mentioned

• Daclizumab (daclizumab)
• Donor Peripheral Stem Cell Transplantation
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED